MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
144.94%
Quick Ratio
102.25%
Cash Ratio
64.22%
Debt to Asset Ratio
102.36%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Intangible Assets Net Excluding ...
    • Trade accounts receivable, net
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid in capital
    • Debt, net of unamortized debt is...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
121,747
111,750
111,042
91,598
Trade accounts receivable, net
58,105
56,295
51,050
53,751
Inventory, net
80,930
74,234
68,673
67,462
Prepaid expenses and other current assets
13,975
9,403
9,548
11,206
Total current assets
274,757
251,682
240,313
224,017
Property and equipment, net
4,834
5,033
4,945
4,946
Operating lease right-of-use assets
21,773
21,949
22,112
22,263
Goodwill
22,859
22,859
22,859
22,859
Intangible Assets Net Excluding Goodwill
82,657
85,368
88,078
90,789
Other Assets Noncurrent
5,025
5,122
5,220
5,317
Total assets
411,905
392,013
383,527
370,191
Accounts payable
9,337
11,467
3,076
6,527
Current portion of long-term debt
63,783
-
0
0
Current operating lease liabilities
6,310
6,271
6,232
6,194
Other accrued liabilities
39,706
32,287
33,155
30,350
Accrued trade discounts and rebates
46,858
45,492
43,253
51,264
Accrued returns reserve
18,598
18,723
18,969
19,216
Other current liabilities
4,976
4,353
4,889
2,649
Total current liabilities
189,568
118,593
109,574
116,200
Debt, net of unamortized debt issuance costs, non-current portion
188,807
221,224
220,335
219,469
Non-current operating lease liabilities
30,542
31,058
31,531
31,991
Other liabilities
12,722
8,127
8,398
3,392
Total liabilities
421,639
379,002
369,838
371,052
Common stockpar value 0.0001, 350,000,000 shares authorized as of june 30, 2026 and december 31, 2025 173,591,637 and 166,215,410 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
18
18
17
17
Additional paid in capital
690,432
682,090
685,004
681,535
Accumulated deficit
-700,174
-669,073
-671,307
-682,388
Accumulated other comprehensive loss
-10
-24
-25
-25
Total stockholders' (deficit) equity
-9,734
13,011
13,689
-861
Total liabilities and stockholders' equity
411,905
392,013
383,527
370,191
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$121,747K (105.36%↑ Y/Y)Inventory, net$80,930K (20.28%↑ Y/Y)Trade accountsreceivable, net$58,105K (9.53%↑ Y/Y)Prepaid expenses andother current assets$13,975K (134.36%↑ Y/Y)Total current assets$274,757K (48.05%↑ Y/Y)Intangible Assets NetExcluding Goodwill$82,657K (-11.60%↓ Y/Y)Goodwill$22,859K (0.00%↑ Y/Y)Operating leaseright-of-use assets$21,773K (-2.81%↓ Y/Y)Other AssetsNoncurrent$5,025K (-0.73%↓ Y/Y)Property and equipment,net$4,834K (-8.52%↓ Y/Y)Total assets$411,905K (23.07%↑ Y/Y)Accumulated deficit-$700,174K (-2.51%↓ Y/Y)Accumulated othercomprehensive loss-$10K (58.33%↑ Y/Y)Total liabilities andstockholders' equity$411,905K (23.07%↑ Y/Y)Total stockholders'(deficit) equity-$9,734K (49.58%↑ Y/Y)Additional paid in capital$690,432K (4.03%↑ Y/Y)Common stockpar value0.0001, 350,000,000...$18K (12.50%↑ Y/Y)Total liabilities$421,639K (19.11%↑ Y/Y)Total currentliabilities$189,568K (99.19%↑ Y/Y)Debt, net ofunamortized debt issuance...$188,807K (-13.64%↓ Y/Y)Non-current operating leaseliabilities$30,542K (-5.85%↓ Y/Y)Other liabilities$12,722K (64.11%↑ Y/Y)Current portion oflong-term debt$63,783K Accrued trade discountsand rebates$46,858K (41.27%↑ Y/Y)Other accruedliabilities$39,706K (59.02%↑ Y/Y)Accrued returns reserve$18,598K (-5.99%↓ Y/Y)Accounts payable$9,337K (-1.32%↓ Y/Y)Current operating leaseliabilities$6,310K (2.50%↑ Y/Y)Other currentliabilities$4,976K (204.72%↑ Y/Y)

Xeris Biopharma Holdings, Inc. (XERS)

Xeris Biopharma Holdings, Inc. (XERS)